Literature DB >> 30570487

TACO and TRALI: biology, risk factors, and prevention strategies.

Nareg Roubinian1.   

Abstract

Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are the leading causes of transfusion-related morbidity and mortality. These adverse events are characterized by acute pulmonary edema within 6 hours of a blood transfusion and have historically been difficult to study due to underrecognition and nonspecific diagnostic criteria. However, in the past decade, in vivo models and clinical studies utilizing active surveillance have advanced our understanding of their epidemiology and pathogenesis. With the adoption of mitigation strategies and patient blood management, the incidence of TRALI and TACO has decreased. Continued research to prevent and treat these severe cardiopulmonary events is focused on both the blood component and the transfusion recipient.
© 2018 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30570487      PMCID: PMC6324877          DOI: 10.1182/asheducation-2018.1.585

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  7 in total

1.  SLC44A2 Frequency, a New TaqMan Real-Time Polymerase Chain Reaction Method for HNA-3A/3B Genotyping, and a New Application of Droplet Digital PCR.

Authors:  Yufeng Wang; Xihui Chen; Qi Chen; Tangdong Chen; Kun Chen; Yuanming Wu; Li Wang
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

2.  Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease.

Authors:  Alma D Del Angel-Pablo; Ivette Buendía-Roldán; Mayra Mejía; Gloria Pérez-Rubio; Karol J Nava-Quiroz; Jorge Rojas-Serrano; Ramcés Falfán-Valencia
Journal:  Cells       Date:  2020-03-11       Impact factor: 6.600

3.  Why Does the Precautionary Principle Suffice for Blood Regulation?

Authors:  Alexandra Seifner; Anthony W Fox
Journal:  Pharmaceut Med       Date:  2021-09-07

4.  High-Dose Convalescent Plasma for Treatment of Severe COVID-19.

Authors:  Gil C De Santis; Luciana Correa Oliveira; Pedro M M Garibaldi; Carlos E L Almado; Julio Croda; Ghislaine G A Arcanjo; Érika A F Oliveira; Adriana C Tonacio; Dante M Langhi; José O Bordin; Renato N Gilio; Leonardo C Palma; Elaine V Santos; Simone K Haddad; Benedito P A Prado; Marjorie Cornejo Pontelli; Rogério Gomes; Carlos H Miranda; Maria Auxiliadora Martins; Dimas T Covas; Eurico Arruda; Benedito A L Fonseca; Rodrigo T Calado
Journal:  Emerg Infect Dis       Date:  2022-01-26       Impact factor: 6.883

Review 5.  A Systematic Review on the Management of Transfusion-Related Acute Lung Injury in Transfusion-Dependent Sickle Cell Disease.

Authors:  Hadia Arzoun; Mirra Srinivasan; Mona Adam; Siji S Thomas; Bridget Lee; Alena Yarema
Journal:  Cureus       Date:  2022-02-10

6.  Plasma Transfusion in Septic Shock-A Secondary Analysis of a Retrospective Single-Center Cohort.

Authors:  Maximilian Dietrich; Tobias Hölle; Lazar Detelinov Lalev; Martin Loos; Felix Carl Fabian Schmitt; Mascha Onida Fiedler; Thilo Hackert; Daniel Christoph Richter; Markus Alexander Weigand; Dania Fischer
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

7.  Chronicle of Hypoxemia: Transfusion-Associated Circulatory Overload Versus Transfusion-Related Acute Lung Injury.

Authors:  Shikha Jha; Keval V Patel; Amar Bukhari
Journal:  Cureus       Date:  2022-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.